- Ochsner exec joins UMC New Orleans as COO
- Boston Children’s saves $7M, 60K hours with OpenAI
- From Calls to Clicks: Where Patient Experience Meets Throughput
- Maternal mental health grades by state
- 6 unique Rural Health Transformation fund proposals
- Illinois hospital taps CFO
- UHS Texas hospital taps new CFO
- Student debt rewrites oral surgery succession plans
- Health systems aren’t just killing more AI projects — they’re starting fewer
- Centerstone begins CEO transition
- 720 hospitals at risk of closure, by state
- Louisiana hospital names chief medical officer
- Nonprofit opens dental center in Maine with $2M in funding
- 16 new behavioral health study findings to know
- A flaw in AI medication monitoring software comes to light after drug diversion in Tennessee hospital
- AdventHealth relocates cardiology practice in Georgia
- Anesthesia under fire: 3 recent legal, policy fights
- Former lab CEO, physician to pay $1.2M+ to settle kickback scheme allegations
- MDMA-assisted therapy, explained
- PDS Health continues de novo growth with 5 new practices
- Commission Statement on the Passing of Former General Counsel David Becker
- 5 highest-paying states for specialty dentists
- Virginia oral surgery center opens 6th office
- New York health system to shutter ASC amid declining patient volume
- North Carolina projects $1B autism therapy spending: 6 notes
- 3 dental leadership moves to know
- CMS outlines national framework to support rollout of Medicaid work requirements
- The rise of the physician side hustle
- How NYU Langone is helping modernize a decades-old GI surgery tool
- The 6 highest-paying practice settings for ophthalmologists
- Dentists’ pay dipped the most in these 10 states
- Where the largest DSOs stand halfway through 2026
- ASCA elects new board president
- 7 physician practices shut their doors in 1 month
- Physician groups welcome IDR rule changes
- Indiana dental office suffers data breach affecting 5,900 individuals
- Your Surprise Medical Bill May Be Gone — But Your Premiums Could Still Spike
- New Connecticut private equity law bans hospital sale-leasebacks
- 17 dentists making headlines
- Mental health ED visits on the rise in 2026: 5 things to know
- How 4 systems are breaking the ED boarding cycle
- Trump signs off on HHS overhaul of childhood vaccine schedule with new executive order
- Trump signs off on HHS overhaul of childhood vaccine schedule with new executive order
- Short-Term Fasting Could Boost Chemo Response in Ovarian Cancer, Study Suggests
- MedTech In Focus: AI impact in healthcare
- MedTech In Focus: AI impact in healthcare
- If Your AI Can’t Explain Itself, Can FDA Authorize It?
- If Your AI Can’t Explain Itself, Can FDA Authorize It?
- Shionogi's COVID antiviral Xocova passes muster with FDA as post-exposure preventative
- How HER2 biology is shaping next-generation cancer treatment
- Workout Habits May Protect Against Inherited Heart Problems
- Childhood Lying Is Normal and Rarely Signals Behavioral Concerns, Study Says
- Perfectionism Among College Students Reaches Record High, Fueling Anxiety
- After Her Bout of Amnesia, A $59,000 Billing Dispute Wouldn't Go Away
- Weed Linked To Higher Testosterone Levels In Young Men
- Amid Ebola, Hantavirus Outbreaks, Democrats Decry Trump’s Health Cuts
- Baffling. Frustrating. Frightening. What It’s Like To Be Sued Over Medical Debt.
- Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight
- ViiV Healthcare launches ‘PrEP Wisdom’ campaign to boost awareness of long-acting HIV prevention meds
- Noom launches at-home biomarker test kit for metabolic health monitoring
- ASCO: AstraZeneca's Imfinzi, Imjudo duo shines in earlier-stage liver cancer
- CVS, Walgreens and Walmart defeat opioid lawsuit brought by Florida hospitals
- ASCO: Sac-TMT’s massive phase 3 program has a jarring gap. Does Merck plan to close it?
- ASCO: Akeso’s ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34%
- ASCO: J&J breaks the prostate cancer treatment mold with fresh Erleada ph. 3 win
- ASCO: Revolution Medicines confident in RAS leadership as rivals square up
- Contraception For Teens: Let's Talk About It
- Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
- ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win
- ASCO: Lilly ties Retevmo to ‘dramatic’ outcomes in early-stage lung cancer with rare RET biomarker
- ASCO: With bispecifics on its heels, Incyte positions Monjuvi combo for first-line DLBCL
- Budget-Strapped Montana Will Stress-Test Trump’s Medicaid Work Rules
- The behavioral health workforce pipeline: Where it stands and where it’s headed
- 6 major investments in youth behavioral health
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Massachusetts AG sues UnitedHealthcare over alleged Medicaid fraud
- Enzo Health launches agentic EHR for home health agencies
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Weekly Rundown—Moffitt Cancer Center expands Reimagine Care's virtual oncology model; Tanner Health deploys AI workforce solution
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- CVS expands partnership with Salesforce for greater call center personalization
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Listen to the Latest ‘KFF Health News Minute’
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- Why direct-to-patient is the future of pharma access
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- Cleveland Clinic, Aspira Women’s Health partner on AI-powered women's health diagnostics
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Remarks at the Stanford Rock Center for Corporate Governance
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
Executive power is one oft-challenged constitutional provision, among many of our day. This decision says, "Yes, the Constitution means exactly what it says."
Score one for constitutional government and healthcare freedom from academic ideological oppression of the professions.
https://www.powerlineblog.com/archives/2026/02/on-dei-a-victory.php
On DEI, a Victory
At the beginning of his administration, President Trump issued two executive orders directing federal agencies to end DEI programs in federal grant and contract processes. Those orders were challenged by plaintiffs that included the City of Baltimore, the American Association of University Professors and the National Association of Diversity Officers in Higher Education. Those plaintiffs sought, and obtained, a preliminary injunction in the district court, preventing implementation of the President’s orders.
Today the Fourth Circuit Court of Appeals, in a decision by two Obama appointees and a Trump appointee, reversed the district court and allowed the Trump administration to implement the executive orders. As usual, the decision was concerned largely with standing and ripeness issues. When Chief Judge Albert Diaz got to the merits, the court’s reasoning was straightforward:
The President may determine his policy priorities and instruct his agents to make funding decisions based on them. See generally 2 C.F.R. § 200.340(a)(4) (2025). President Trump has decided that equity isn’t a priority in his administration and so has directed his subordinates to terminate funding that supports equity-related projects to the maximum extent allowed by law. Whether that’s sound policy or not isn’t our call. We ask only whether the policy is unconstitutionally vague for funding recipients.
The court then rejected the plaintiffs’ First Amendment argument:
The First Amendment precludes the government from “abridging the freedom of speech.” Reed v. Town of Gilbert, 576 U.S. 155, 163 (2015) (quoting U.S. Const. amend. I). So generally, “the government may not regulate speech based on its substantive content or the message it conveys.” Rosenberger v. Rector & Visitors of Univ. of Va., 515 U.S. 819, 828 (1995).
But this case arises in the funding context. There, as we’ve explained, the government “has wide latitude to set spending priorities” and “to ch[oose] to fund one activity to the exclusion of the other.” Finley, 524 U.S. at 588 (citation modified). But again, the latitude isn’t limitless. …
To start, to make out a First Amendment claim, “[p]laintiffs must show that the certification requirement impermissibly restricts their ability to engage in protected speech.” Nat’l Urban League, 783 F. Supp. 3d at 102. But the Provision [the portion of the executive order at issue] requires only that plaintiffs certify compliance with federal antidiscrimination laws, which the First Amendment doesn’t confer a right to violate. See S.F. AIDS Found., 786 F. Supp. 3d at 1222 (“[W]hile the First Amendment may protect speech that advocates for violation of law, it does not protect activities that directly violate antidiscrimination law.”). Put another way, plaintiffs have no protectable speech interest in operating, and “no constitutional right to operate[,] DEI programs that violate federal antidiscrimination law.” Nat’l Urban League, 783 F. Supp. 3d at 102.
This wasn’t a close case. Is there any serious question that the Executive Branch, in directing grants, can adhere to the priorities of the Executive Branch? And how can it be controversial to require grant recipients to certify that they are not violating federal antidiscrimination law?
And yet, these plaintiffs won in the trial court, and were supported on appeal by an array of amici that included 18 states and a number of private employers, along with other organizations–the establishment, in effect. Basically, these parties argued for the proposition that the federal government must adhere to liberal ideology, no matter what the electorate might vote for, and no matter what the Constitution and federal law may provide. That is, indeed, the Democratic Party’s position, and it was expressed starkly in this case.
That view has been defeated, at least for the moment, and the Executive Branch has been freed to do what Americans voted for. It should be noted, however, that liberals, through their frivolous lawsuit and with the connivance of a Democratic Party judge, delayed for a year implementation of the Trump administration’s requirement that federal grantees not engage in illegal discrimination.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















